# Renin and Renal Biomarker Response to Angiotensin II

> **NCT04558359** · PHASE4 · COMPLETED · sponsor: **Alexander Flannery** · enrollment: 30 (actual)

## Conditions studied

- Septic Shock
- Acute Kidney Injury

## Interventions

- **OTHER:** Standard of Care
- **DRUG:** Angiotensin II

## Key facts

- **NCT ID:** NCT04558359
- **Lead sponsor:** Alexander Flannery
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-19
- **Primary completion:** 2023-07-24
- **Final completion:** 2023-07-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04558359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04558359, "Renin and Renal Biomarker Response to Angiotensin II". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04558359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*